1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Synthetic Opioids Revenue
1.4 Market Analysis by Type
1.4.1 Global Synthetic Opioids Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Methadone
1.4.3 Fentanyl
1.4.4 Meperidine
1.4.5 Hydrocodone
1.4.6 Oxymorphone
1.4.7 Oxycodone
1.5 Market by Application
1.5.1 Global Synthetic Opioids Market Share by Application: 2021-2026
1.5.2 Pain Management
1.5.3 De-addiction
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Synthetic Opioids Market
1.8.1 Global Synthetic Opioids Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Synthetic Opioids Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Synthetic Opioids Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Synthetic Opioids Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Synthetic Opioids Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Synthetic Opioids Sales Volume Market Share by Region (2015-2020)
3.2 Global Synthetic Opioids Sales Revenue Market Share by Region (2015-2020)
3.3 North America Synthetic Opioids Sales Volume
3.3.1 North America Synthetic Opioids Sales Volume Growth Rate (2015-2020)
3.3.2 North America Synthetic Opioids Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Synthetic Opioids Sales Volume
3.4.1 East Asia Synthetic Opioids Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Synthetic Opioids Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Synthetic Opioids Sales Volume (2015-2020)
3.5.1 Europe Synthetic Opioids Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Synthetic Opioids Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Synthetic Opioids Sales Volume (2015-2020)
3.6.1 South Asia Synthetic Opioids Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Synthetic Opioids Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Synthetic Opioids Sales Volume (2015-2020)
3.7.1 Southeast Asia Synthetic Opioids Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Synthetic Opioids Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Synthetic Opioids Sales Volume (2015-2020)
3.8.1 Middle East Synthetic Opioids Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Synthetic Opioids Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Synthetic Opioids Sales Volume (2015-2020)
3.9.1 Africa Synthetic Opioids Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Synthetic Opioids Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Synthetic Opioids Sales Volume (2015-2020)
3.10.1 Oceania Synthetic Opioids Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Synthetic Opioids Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Synthetic Opioids Sales Volume (2015-2020)
3.11.1 South America Synthetic Opioids Sales Volume Growth Rate (2015-2020)
3.11.2 South America Synthetic Opioids Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Synthetic Opioids Sales Volume (2015-2020)
3.12.1 Rest of the World Synthetic Opioids Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Synthetic Opioids Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Synthetic Opioids Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Synthetic Opioids Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Synthetic Opioids Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Synthetic Opioids Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Synthetic Opioids Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Synthetic Opioids Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Synthetic Opioids Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Synthetic Opioids Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Synthetic Opioids Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Synthetic Opioids Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Synthetic Opioids Sales Volume Market Share by Type (2015-2020)
14.2 Global Synthetic Opioids Sales Revenue Market Share by Type (2015-2020)
14.3 Global Synthetic Opioids Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Synthetic Opioids Consumption Volume by Application (2015-2020)
15.2 Global Synthetic Opioids Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Synthetic Opioids Business
16.1 Purdue Pharma
16.1.1 Purdue Pharma Company Profile
16.1.2 Purdue Pharma Synthetic Opioids Product Specification
16.1.3 Purdue Pharma Synthetic Opioids Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Mylan
16.2.1 Mylan Company Profile
16.2.2 Mylan Synthetic Opioids Product Specification
16.2.3 Mylan Synthetic Opioids Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Teva Pharmaceuticals
16.3.1 Teva Pharmaceuticals Company Profile
16.3.2 Teva Pharmaceuticals Synthetic Opioids Product Specification
16.3.3 Teva Pharmaceuticals Synthetic Opioids Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Pfizer
16.4.1 Pfizer Company Profile
16.4.2 Pfizer Synthetic Opioids Product Specification
16.4.3 Pfizer Synthetic Opioids Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Mallinckrodt Pharmaceuticals
16.5.1 Mallinckrodt Pharmaceuticals Company Profile
16.5.2 Mallinckrodt Pharmaceuticals Synthetic Opioids Product Specification
16.5.3 Mallinckrodt Pharmaceuticals Synthetic Opioids Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Janssen Pharmaceuticals
16.6.1 Janssen Pharmaceuticals Company Profile
16.6.2 Janssen Pharmaceuticals Synthetic Opioids Product Specification
16.6.3 Janssen Pharmaceuticals Synthetic Opioids Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Indivior
16.7.1 Indivior Company Profile
16.7.2 Indivior Synthetic Opioids Product Specification
16.7.3 Indivior Synthetic Opioids Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 West-Ward Pharmaceuticals
16.8.1 West-Ward Pharmaceuticals Company Profile
16.8.2 West-Ward Pharmaceuticals Synthetic Opioids Product Specification
16.8.3 West-Ward Pharmaceuticals Synthetic Opioids Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Endo International
16.9.1 Endo International Company Profile
16.9.2 Endo International Synthetic Opioids Product Specification
16.9.3 Endo International Synthetic Opioids Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Impax Laboratories
16.10.1 Impax Laboratories Company Profile
16.10.2 Impax Laboratories Synthetic Opioids Product Specification
16.10.3 Impax Laboratories Synthetic Opioids Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Synthetic Opioids Manufacturing Cost Analysis
17.1 Synthetic Opioids Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Synthetic Opioids
17.4 Synthetic Opioids Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Synthetic Opioids Distributors List
18.3 Synthetic Opioids Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Synthetic Opioids (2021-2026)
20.2 Global Forecasted Revenue of Synthetic Opioids (2021-2026)
20.3 Global Forecasted Price of Synthetic Opioids (2015-2026)
20.4 Global Forecasted Production of Synthetic Opioids by Region (2021-2026)
20.4.1 North America Synthetic Opioids Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Synthetic Opioids Production, Revenue Forecast (2021-2026)
20.4.3 Europe Synthetic Opioids Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Synthetic Opioids Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Synthetic Opioids Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Synthetic Opioids Production, Revenue Forecast (2021-2026)
20.4.7 Africa Synthetic Opioids Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Synthetic Opioids Production, Revenue Forecast (2021-2026)
20.4.9 South America Synthetic Opioids Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Synthetic Opioids Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Synthetic Opioids by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Synthetic Opioids by Country
21.2 East Asia Market Forecasted Consumption of Synthetic Opioids by Country
21.3 Europe Market Forecasted Consumption of Synthetic Opioids by Countriy
21.4 South Asia Forecasted Consumption of Synthetic Opioids by Country
21.5 Southeast Asia Forecasted Consumption of Synthetic Opioids by Country
21.6 Middle East Forecasted Consumption of Synthetic Opioids by Country
21.7 Africa Forecasted Consumption of Synthetic Opioids by Country
21.8 Oceania Forecasted Consumption of Synthetic Opioids by Country
21.9 South America Forecasted Consumption of Synthetic Opioids by Country
21.10 Rest of the world Forecasted Consumption of Synthetic Opioids by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer